Sign In
Buy IDXG
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
Next Generation Cancer Diagnostics: Technologies and Global Markets (2019-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 25'th Aug 2020
The
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Clovis Rubraca Data, And Other News: The Good, Bad And Ugly Of Biopharma
11:52am, Tuesday, 18'th Aug 2020
Clovis reports positive data from TRITON clinical trial. Interpace Biosciences sinks on potential compliance roadblocks.
Luminex Corp (DE) (LMNX) Q2 2020 Earnings Call Transcript | The Motley Fool
06:01am, Wednesday, 05'th Aug 2020
LMNX earnings call for the period ending June 30, 2020.
QIAGEN Reports Full Results for Second Quarter and First Half Of 2020
12:00am, Tuesday, 04'th Aug 2020
QIAGEN reports full results for second quarter and first half of 2020
Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid Assays
10:05am, Tuesday, 21'st Jul 2020
Podium Presentation Accepted for the American Society of Cytopathology (ASC) Annual Meeting PARSIPPANY, NJ, July 21, 2020 -- Interpace Biosciences, Inc. (NASDAQ: IDXG).
The
Interpace Diagnostics Group (NASDAQ:IDXG) Cut to “Buy” at ValuEngine
02:22am, Friday, 03'rd Jul 2020
Interpace Diagnostics Group (NASDAQ:IDXG) was downgraded by stock analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued on Friday, ValuEngine reports. A
Oppenheimer Sticks to Its Buy Rating for Moleculin Biotech (MBRX) - Markets
04:54pm, Thursday, 02'nd Jul 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Moleculin Biotech (MBRX – Research Report),
H.C. Wainwright Initiates a Buy Rating on Applied DNA Sciences (APDN) - Markets
10:07am, Thursday, 02'nd Jul 2020
In a report released today, Yi Chen from H.C. Wainwright initiated coverage with a Buy rating on Applied DNA Sciences
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.36%
12:00am, Thursday, 02'nd Jul 2020
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.36%
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
Interpace Diagnostics Group (NASDAQ:IDXG) Posts Earnings Results, Misses Estimates By $1.08 EPS
08:02am, Sunday, 28'th Jun 2020
Interpace Diagnostics Group (NASDAQ:IDXG) announced its quarterly earnings results on Thursday. The business services provider reported ($2.32) earnings per share for the quarter, missing analysts’
